Fueled by the combined resources of IQVIA and Quest Diagnostics, the Q2
Solutions joint venture was formed in 2015 by combining the best of each parent organizations clinical trials laboratory services capabilities in order to provide greater innovation, quality and value for our customers.
Our global laboratory network combines IQVIA’s global scale, clinical trial expertise, and diverse therapeutic experience with Quest Diagnostics’ operational, scientific and quality excellence, supply-chain network, and informatics.
This unique combination of capabilities allows us to deliver greater innovation, quality and value for biopharmaceutical customers, and to help our customers bring new medicines to market faster.
We offer end-to-end lab services across the development continuum. Discover how we employ the newly integrated Central Laboratories
, Bioanalytical and ADME Laboratories
, Anatomic Pathology
, Precision Medicine
, Companion Diagnostics
, and Vaccine
testing services to shape better outcomes for your drug development programs.
The joint venture was borne out of a shared commitment to quality, customer service and – above all – helping bring new treatments to patients.
Learn more about Q2
Solutions and how we can put our tailored solutions
, delivery excellence
, and shaping outcomes
to work for you.